The optical properties of line-defect waveguides in two-dimensional photonic crystal slabs are investigated using picosecond light pulses. Time-domain waveforms of the light pulse propagating through the waveguide are successfully observed using an autocorrelation method. The group velocity of the waveguide is directly determined from the group delay time for light pulses reflected back and forth along the waveguide. A small group velocity of one-twentieth the speed of light in vacuum is observed at a frequency near the edge of the waveguide mode. The frequency dependence of the group velocity is also measured, and the group-velocity dispersion is found to be larger than that of normal single-mode optical fibers by a factor of 10 4-10 5 .
We investigated propagating modes in a two-dimensional photonic crystal slab waveguide with a line defect narrower than a single line missing hole structure from the low group velocity point of view. These modes showed low group velocities not due to the conventional distributed feedback (DFB) between a forward and a backward mode with the same lateral field distribution, but due to a DFB between modes with different lateral field distribution or property of a start point of a photonic-band-gap-guided mode. These low group velocities of over 40 were demonstrated as a Fabry-Pérot lasing oscillation due to gain enhancement.
The optical absorption coefficients of carbon-doped GaAs in a wide range of doping concentrations (10 18 to 10 20 cm À3 ) were measured by waveguide propagation loss and wafer measurements. Experimental data indicate twofold higher absorption coefficients for C-doped GaAs than for Zn-doped GaAs at a wavelength of 1300 nm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.